leisure time -WSS

leisure time

author：comprehensive 2025-09-29 22:46:48 - browse：9534

Doctor Monica Bertagnolli, a white woman with short hair and bangs, sits at a hearing behind her name tag — coverage from STAT — National Institutes of Health Director Monica Bertagnolli testifies during her Senate HELP Committee confirmation hearing on Oct. 18 in Washington. Kevin Dietsch/Getty Images

WASHINGTON — The new National Institutes of Health director, Monica Bertagnolli, said it’s a “failure” that enrollment in government-funded clinical trials has lagged behind those funded by the pharmaceutical industry.

“If you just look at the number of patients who go on government-funded trials, it’s been completely flat over the last decade,” she said at a meeting of the advocacy group Friends of Cancer Research. “If you go and look at the number of people who go on pharma-sponsored trials, it’s just this commitment and this increase.”

A Johns Hopkins University study published in 2015 showed that the pharmaceutical industry funds six times more clinical trials than the government. Industry-sponsored trials increased 43% from 2006 to 2014, while newly registered NIH-funded trials decreased 24% over the same period.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： STAT Readout Newsletter: Biotech news today

knowledge

WSS

STAT Summit: The economic case for universal basic health care

Inside the rise of 'mukbang' eating videos

Cassava Sciences’ Alzheimer’s clinical trials should be halted

ADCs take center stage as promising cancer treatments

Merck, Daiichi strike cancer drug pact worth up to $22 billion

The thinking behind the controversial eating disorder chatbot Tessa

entertainment

leisure time

knowledge

Cancer drug shortages should be causing more outrage

J&J lung cancer data amount to new salvo against AstraZeneca

Trump demands the U.S. pay no more for drugs than other countries … again

Merck, Daiichi strike cancer drug pact worth up to $22 billion

Heart attack and stroke risk calculators need revising

Living organ donors deserve priority status for transplants

Psychedelics group wrestles with new pharma identity

Biogen nominates mother of director’s child to replace him on board

Dobbs anniversary: the lost opportunity of abortion as health care

Readout LOUD podcast: Live from the 2023 STAT Summit

entertainment

Reanimated hearts work just as well for transplants, study finds

A public health expert passes on football's full body collisions for youths

Living organ donors deserve priority status for transplants

Readout LOUD podcast: Live from the 2023 STAT Summit

Biden administration plans revamp of organ transplant system

Senate panel passes drug pricing bills, but drops one PBM reform

leisure time

knowledge

knowledge

focus